Hercules Capital Inc.
Hercules Capital, Inc. is a business development company. The firm specializing in providing venture debt, debt, senior secured loans, and growth capital to privately held venture capital-backed companies at all stages of development from startups, to expansion stage including select publicly listed companies and select special opportunity lower middle market companies that require additional capital to fund acquisitions, recapitalizations and refinancing and established-stage companies. The firm provides growth capital financing solutions for capital extension; management buy-out and corporate spin-out financing solutions; company, asset specific, or intellectual property acquisition financing; convertible, subordinated and/or mezzanine loans; domestic and international corporate expansion; vendor financing; revenue acceleration by sales and marketing development, and manufacturing expansion. It provides asset-based financing with a focus on cash flow; accounts receivable facilities; equipment loans or leases; equipment acquisition; facilities build-out and/or expansion; working capital revolving lines of credit; inventory. The firm also provides bridge financing to IPO or mergers and acquisitions or technology acquisition; dividend recapitalizations and other sources of investor liquidity; cash flow financing to protect against share price volatility; competitor acquisition; pre-IPO financing for extra cash on the balance sheet; public company financing to continue asset growth and production capacity; short-term bridge financing; and strategic and intellectual property acquisition financings. It also focuses on customized financing solutions, emerging growth, mid venture, and late venture financing. The firm invests primarily in structured debt with warrants and, to a lesser extent, in senior debt and equity investments. The firm generally seeks to invest in companies that have been operating for at least six to 12 months prior to the date of their investment. It prefers to invest in technology, energy technology, sustainable and renewable technology, and life sciences. Within technology the firm focuses on advanced specialty materials and chemicals; communication and networking, consumer and business products; consumer products and services, digital media and consumer internet; electronics and computer hardware; enterprise software and services; gaming; healthcare services; information services; business services; media, content and information; mobile; resource management; security software; semiconductors; semiconductors and hardware; and software sector. Within energy technology, it invests in agriculture; clean technology; energy and renewable technology, fuels and power technology; geothermal; smart grid and energy efficiency and monitoring technologies; solar; and wind. Within life sciences, the firm invests in biopharmaceuticals; biotechnology tools; diagnostics; drug discovery, development and delivery; medical devices and equipment; surgical devices; therapeutics; pharma services; and specialty pharmaceuticals. It also invests in educational services. The firm invests primarily in United States based companies and considers investment in the West Coast, Mid-Atlantic regions, Southeast and Midwest; particularly in the areas of software, biotech and information services. It invests generally between $1 million to $40 million in companies focused primarily on business services, communications, electronics, hardware, and healthcare services. The firm invests primarily in private companies but also have investments in public companies. For equity investments, the firm seeks to represent a controlling interest in its portfolio companies which may exceed 25% of the voting securities of such companies. The firm seeks to invest a limited portion of its assets in equipment-based loans to early-stage prospective portfolio companies. These loans are generally for amounts up to $3 million but may be up to $15 million for certain energy technology venture investments. The firm allows certain debt investments have the right to convert a portion of the debt investment into equity. It also co-invests with other private equity firms. The firm seeks to exit its investments through initial public offering, a private sale of equity interest to a third party, a merger or an acquisition of the company or a purchase of the equity position by the company or one of its stockholders. The firm has structured debt with warrants which typically have maturities of between two and seven years with an average of three years; senior debt with an investment horizon of less than three years; equipment loans with an investment horizon ranging from three to four years; and equity related securities with an investment horizon ranging from three to seven years. The firm prefers to invest through its balance sheet capital. The firm formerly known as Hercules Technology Growth Capital, Inc. Hercules Capital, Inc. was founded in Decembe
IPO Year: 2012
Exchange: NYSE
Website: htgc.com
Recent Analyst Ratings for Hercules Capital Inc.
| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 12/12/2024 | $19.50 → $21.50 | Mkt Perform → Outperform | Keefe Bruyette |
| 1/16/2024 | $17.00 → $17.50 | Buy → Neutral | Compass Point |
| 11/21/2023 | $17.00 | Neutral | UBS |
| 8/30/2023 | $17.50 | Neutral → Buy | Compass Point |
| 8/4/2023 | $13.50 → $17.00 | Underperform → Mkt Perform | Keefe Bruyette |
| 4/6/2023 | $16.00 | Neutral → Overweight | Piper Sandler |
| 3/13/2023 | $14.50 → $10.50 | Mkt Perform → Underperform | Keefe Bruyette |
| 7/29/2022 | Outperform → Perform | Oppenheimer | |
| 4/22/2022 | $18.00 | Outperform → Mkt Perform | Keefe Bruyette |
| 4/4/2022 | $19.00 | Overweight → Neutral | Piper Sandler |
Hercules Capital Inc. Press Releases
Fastest customizable press release news feed in the world
Savara Enters Into Non-Dilutive Debt Financing for up to $200M With Hercules Capital
Includes $30M at Close to Refinance Existing Debt Facility Savara Inc. (NASDAQ:SVRA) (the Company), a clinical stage biopharmaceutical company focused on rare respiratory diseases, today announced that it has entered into a loan and security agreement with Hercules Capital, Inc. (NYSE:HTGC), for up to $200 million. Access to the additional capital strengthens Savara's balance sheet following the submission of the Biologics License Application (BLA) to the U.S. Food and Drug Administration (FDA) for MOLBREEVI* as a treatment for autoimmune pulmonary alveolar proteinosis (aPAP). If Priority Review is granted by the FDA, MOLBREEVI could potentially be approved by the end of the year. The Comp
Hercules Capital Closes Offering of $287.5 Million of Convertible Unsecured Notes
Convertible Unsecured Notes due 2028 Initially Assigned a BBB+ by Kroll Bond Rating Agency Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), today announced that it has closed a private offering of $287.5 million aggregate principal amount of its 4.750% Convertible Unsecured Notes due 2028 (the "Convertible Notes"), which amount includes the additional $37.5 million aggregate principal amount of Convertible Notes issued pursuant to the initial purchasers' exercise in full of its overallotment option. The Convertible Notes were sold only to qualified institutional buyers (as defined in the Securities Act of 1933, as amended (the "Securities Act")) pursuant to Rule 144A under
Hercules Capital Receives Investment Grade Rating Upgrade to BBB (high) with Revised Outlook to Stable from Morningstar DBRS
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Morningstar DBRS ("DBRS") has upgraded Hercules' investment grade credit and corporate rating to BBB (high) from BBB with a trend revision from Positive to Stable, as well as its underlying analysis. "We are very pleased that DBRS has upgraded our investment grade credit and corporate rating to BBB (high) with a revised outlook to stable," stated Seth Meyer, chief financial officer of Hercules. "This
KBRA Assigns Rating to Hercules Capital, Inc.'s $250 Million Convertible Unsecured Notes Due 2028
KBRA assigns a rating of BBB+ to Hercules Capital, Inc.'s (NYSE:HTGC) $250 million 4.75% convertible unsecured notes due September 2028. The rating Outlook is Stable. Key Credit Considerations The rating reflects the company's diversified $3.66 billion investment portfolio consisting of 118 portfolio companies (debt investments) with a focus on senior secured first lien venture debt investments (86.9%) in the technology and life sciences sectors, solid 20-year operating history, including during the global financial crisis, and appropriate leverage metrics. The company's solid credit quality has benefited from the company's robust risk management and solid investment team with years of ex
Hercules Capital Prices $250.0 Million of Convertible Unsecured Notes
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), today announced that it has agreed to sell to the initial purchasers in a private offering, $250.0 million aggregate principal amount of its 4.75% Convertible Unsecured Notes due 2028 (the "Convertible Notes"). The Company also has granted the initial purchasers an option to purchase up to an additional $37.5 million principal amount of the Convertible Notes to cover overallotments, if any. The Convertible Notes will be offered only to qualified institutional buyers (as defined in the Securities Act of 1933, as amended (the "Securities Act")) pursuant to Rule 144A under the Securities Act. The closing of the transaction is su
Hercules Capital Announces Offering of $250.0 Million of Convertible Unsecured Notes
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), today announced that it plans to make an offering of $250.0 million aggregate principal amount of its Convertible Unsecured Notes due 2028 (the "Convertible Notes"). The Company plans to grant the initial purchasers an option to purchase up to an additional $37.5 million principal amount of the Convertible Notes to cover overallotments, if any. The Convertible Notes will be offered only to qualified institutional buyers (as defined in the Securities Act of 1933, as amended (the "Securities Act")) pursuant to Rule 144A under the Securities Act and to certain non-U.S. persons outside of the United States pursuant to Regulation
Hercules Capital Reports Fourth Quarter and Full-Year 2024 Financial Results
Record Full-Year 2024 Total Investment Income of $493.6 Million, an Increase of 7.1% Year-over-Year Record Full-Year 2024 Net Investment Income "NII" of $325.8 Million, an Increase of 7.2% Year-over-Year Record Full-Year 2024 Gross Fundings of $1.81 Billion, an Increase of 13.0% Year-over-Year Q4 2024 NII of $81.1 Million, or $0.49 per Share, provides 123% Coverage of the Base Cash Distribution Q4 2024 Total Gross Debt and Equity Commitments of $619.5 Million Q4 2024 Total Gross Fundings of $468.5 Million Conservative Balance Sheet Management with Net GAAP Leverage of 83.9% and Net Regulatory Leverage of 69.9% Inclusive of the Adviser Funds Managed by Hercules Adviser LLC, its
Hercules Capital Announces New Supplemental Cash Distribution of $0.28 per Share
The New Supplemental Cash Distribution is in Addition to the Regular Quarterly Cash Distributions and will be Distributed Equally over Four Quarters Beginning with the Fourth Quarter of 2024 Distribution Payable in March of 2025 The New Supplemental Cash Distribution of $0.07 per Share for the Fourth Quarter of 2024 is in Addition to the Regular Quarterly Cash Distribution of $0.40 per Share Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that
Hercules Capital Declares a Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2024
The Total Cash Distribution of $0.47 per Share for the Fourth Quarter 2024 is Comprised of a $0.40 per Share Base Distribution and a $0.07 per Share Supplemental Distribution Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty finance provider to innovative, venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, is pleased to announce that its Board of Directors has declared a fourth quarter 2024 total cash distribution of $0.47 per share. The following shows the key dates of the fourth quarter 2024 distribution payment: Record Date February 26,
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2024 financial results conference call for Thursday, February 13, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can b
Hercules Capital Inc. Analyst Ratings
Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.
Hercules Capital upgraded by Keefe Bruyette with a new price target
Keefe Bruyette upgraded Hercules Capital from Mkt Perform to Outperform and set a new price target of $21.50 from $19.50 previously
Hercules Capital downgraded by Compass Point with a new price target
Compass Point downgraded Hercules Capital from Buy to Neutral and set a new price target of $17.50 from $17.00 previously
UBS initiated coverage on Hercules Capital with a new price target
UBS initiated coverage of Hercules Capital with a rating of Neutral and set a new price target of $17.00
Hercules Capital upgraded by Compass Point with a new price target
Compass Point upgraded Hercules Capital from Neutral to Buy and set a new price target of $17.50
Hercules Capital upgraded by Keefe Bruyette with a new price target
Keefe Bruyette upgraded Hercules Capital from Underperform to Mkt Perform and set a new price target of $17.00 from $13.50 previously
Hercules Capital upgraded by Piper Sandler with a new price target
Piper Sandler upgraded Hercules Capital from Neutral to Overweight and set a new price target of $16.00
Hercules Capital downgraded by Keefe Bruyette with a new price target
Keefe Bruyette downgraded Hercules Capital from Mkt Perform to Underperform and set a new price target of $10.50 from $14.50 previously
Hercules Capital downgraded by Oppenheimer
Oppenheimer downgraded Hercules Capital from Outperform to Perform
Hercules Capital downgraded by Keefe Bruyette with a new price target
Keefe Bruyette downgraded Hercules Capital from Outperform to Mkt Perform and set a new price target of $18.00
Hercules Capital downgraded by Piper Sandler with a new price target
Piper Sandler downgraded Hercules Capital from Overweight to Neutral and set a new price target of $19.00
Hercules Capital Inc. Insider Purchases
Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.
Director Theodosopoulos Nikos bought $28,997 worth of shares (1,608 units at $18.03), increasing direct ownership by 40% to 5,613 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Randhawa Paramjeet K bought $52,378 worth of shares (2,898 units at $18.07), increasing direct ownership by 22% to 15,972 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Crowell Gayle A bought $104,592 worth of shares (5,790 units at $18.06), increasing direct ownership by 11% to 59,366 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Loo Wade was granted 1,596 shares, bought $104,676 worth of shares (5,645 units at $18.54) and returned 1,596 shares to the company, increasing direct ownership by 131% to 7,150 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Aguirre Deanne bought $104,661 worth of shares (5,660 units at $18.49), returned 4,521 shares to the company and was granted 4,521 shares, increasing direct ownership by 21% to 7,530 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Fallon Thomas J returned 1,158 shares to the company, was granted 1,158 shares and bought $104,885 worth of shares (5,723 units at $18.33), decreasing direct ownership by 15% to 6,789 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Director Crowell Gayle A bought $14,067 worth of shares (702 units at $20.05), increasing direct ownership by 1% to 53,576 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Hercules Capital Inc. Insider Trading
Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.
Chief Financial Officer Meyer Seth H covered exercise/tax liability with 7,721 shares, decreasing direct ownership by 2% to 393,083 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Operating Officer Follmann Christian covered exercise/tax liability with 1,256 shares, decreasing direct ownership by 1% to 122,505 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Legal Officer & CCO Botelho Kiersten Zaza covered exercise/tax liability with 1,032 shares, decreasing direct ownership by 1% to 69,194 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Executive Officer Bluestein Scott covered exercise/tax liability with 22,006 shares, decreasing direct ownership by 0.94% to 2,315,881 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Operating Officer Follmann Christian covered exercise/tax liability with 4,266 shares and was granted 33,784 shares, increasing direct ownership by 31% to 123,761 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Financial Officer Meyer Seth H covered exercise/tax liability with 16,351 shares and was granted 82,583 shares, increasing direct ownership by 20% to 400,804 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Legal Officer & CCO Botelho Kiersten Zaza covered exercise/tax liability with 4,295 shares and was granted 27,528 shares, increasing direct ownership by 49% to 70,226 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Executive Officer Bluestein Scott covered exercise/tax liability with 43,034 shares and was granted 241,742 shares, increasing direct ownership by 9% to 2,337,887 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Chief Financial Officer Meyer Seth H was granted 132 shares, increasing direct ownership by 0.04% to 334,572 units (SEC Form 4)
4 - Hercules Capital, Inc. (0001280784) (Issuer)
SEC Form 4 filed by Chief Operating Officer Follmann Christian
4 - Hercules Capital, Inc. (0001280784) (Issuer)
Hercules Capital Inc. SEC Filings
Hercules Capital Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement, Regulation FD Disclosure
8-K - Hercules Capital, Inc. (0001280784) (Filer)
Hercules Capital Inc. filed SEC Form 8-K: Regulation FD Disclosure
8-K - Hercules Capital, Inc. (0001280784) (Filer)
Hercules Capital Inc. filed SEC Form 8-K: Regulation FD Disclosure
8-K - Hercules Capital, Inc. (0001280784) (Filer)
SEC Form ABS-15G filed by Hercules Capital Inc.
ABS-15G - Hercules Capital, Inc. (0001280784) (Filer)
Hercules Capital Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Other Events, Financial Statements and Exhibits
8-K - Hercules Capital, Inc. (0001280784) (Filer)
SEC Form 10-K filed by Hercules Capital Inc.
10-K - Hercules Capital, Inc. (0001280784) (Filer)
Hercules Capital Inc. filed SEC Form 8-K: Entry into a Material Definitive Agreement
8-K - Hercules Capital, Inc. (0001280784) (Filer)
SEC Form 40-17G filed by Hercules Capital Inc.
40-17G - Hercules Capital, Inc. (0001280784) (Filer)
SEC Form 8-K filed by Hercules Capital Inc.
8-K - Hercules Capital, Inc. (0001280784) (Filer)
SEC Form N-2ASR filed by Hercules Capital Inc.
N-2ASR - Hercules Capital, Inc. (0001280784) (Filer)
Hercules Capital Inc. Leadership Updates
Live Leadership Updates
Revelation Partners Expands Team with Hire of Andrew Olson, Partner, Chief Financial Officer & Chief Operating Officer
SAUSALITO, Calif., Nov. 29, 2023 /PRNewswire/ -- Revelation Partners, a healthcare investment firm with over $1.5 billion of capital under management, announced today the addition of Andrew Olson as Partner, Chief Financial Officer and Chief Operating Officer. Mr. Olson has an extensive background in the venture capital and funds management industry. His addition to the team will enhance the firm's technical expertise, support the differentiated investment model, and strengthen the firm's ongoing foundation. As the firm's new Chief Financial Officer and Chief Operating Officer
Hercules Capital Announces the Appointment of Mr. Nikos Theodosopoulos to Its Board of Directors
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Nikos Theodosopoulos was appointed to serve as an independent member of its board of directors, effective September 21, 2023. Mr. Theodosopoulos is an experienced corporate executive and board director with more than 38 years in senior management roles in both the financial services and technology industries. Mr. Theodosopoulos will serve on the Company's Audit Committee. "Nikos' combined experienc
Hercules Capital Announces the Appointment of Ms. DeAnne Aguirre to Its Board of Directors
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that DeAnne Aguirre was appointed to serve as an independent member of its board of directors, effective June 23, 2022. Ms. Aguirre is an experienced corporate executive and Board Director with more than 30 years in senior leadership managing large and complex domestic and international business units. Ms. Aguirre will serve on the Nominating and Corporate Governance Committee. "As we continue to expand o
Hercules Capital Announces the Appointment of Ms. Pam Randhawa to Its Board of Directors
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that Pam Randhawa was appointed to serve as a member of its board of directors, effective November 1, 2021. Ms. Randhawa is a thought leader within the life sciences sector and an experienced industry executive, with more than 20 years of experience leading public and private companies, ranging from biotech, healthcare and sustainable solutions, through their various stages of growth. Ms. Randhawa will ser
Hercules Capital Announces the Appointment of Wade Loo to Its Board of Directors
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that effective July 1, 2021, Wade Loo was appointed to the Hercules board of directors. Mr. Loo brings over 40 years of business experience in all aspects of financial reporting serving public companies – from emerging startups going public to large-cap multinationals. Mr. Loo will serve on the Audit Committee. "Wade provides relevant financial business expertise that complements our leading venture lendi
Hercules Capital Inc. Financials
Live finance-specific insights
Hercules Capital Reports Fourth Quarter and Full-Year 2024 Financial Results
Record Full-Year 2024 Total Investment Income of $493.6 Million, an Increase of 7.1% Year-over-Year Record Full-Year 2024 Net Investment Income "NII" of $325.8 Million, an Increase of 7.2% Year-over-Year Record Full-Year 2024 Gross Fundings of $1.81 Billion, an Increase of 13.0% Year-over-Year Q4 2024 NII of $81.1 Million, or $0.49 per Share, provides 123% Coverage of the Base Cash Distribution Q4 2024 Total Gross Debt and Equity Commitments of $619.5 Million Q4 2024 Total Gross Fundings of $468.5 Million Conservative Balance Sheet Management with Net GAAP Leverage of 83.9% and Net Regulatory Leverage of 69.9% Inclusive of the Adviser Funds Managed by Hercules Adviser LLC, its
Hercules Capital Announces Date for Release of Fourth Quarter and Full-Year 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its fourth quarter and full-year 2024 financial results conference call for Thursday, February 13, 2025, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can b
Hercules Capital Reports Third Quarter 2024 Financial Results
Record Q3 2024 Total Investment Income of $125.2 Million, an Increase of 7.3% Year-over-Year Q3 2024 Net Investment Income "NII" of $83.2 Million, or $0.51 per Share, an Increase of 8.3% Year-over-Year Q3 2024 NII Provides 128% Coverage of the Base Cash Distribution Q3 2024 Total Gross Debt and Equity Commitments of $430.7 Million Q3 2024 Total Gross Fundings of $272.0 Million Conservative Balance Sheet Management with Net GAAP Leverage of 92.5% and Net Regulatory Leverage of 83.0% Undistributed Earnings Spillover of $152.1 Million, or $0.94(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an Increase of 10.9% Year-over-Year(2) Hercules Capital
Hercules Capital Announces Date for Release of Third Quarter 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its third quarter 2024 financial results conference call for Wednesday, October 30, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access
Hercules Capital Reports Second Quarter 2024 Financial Results
Q2 2024 Total Gross Debt and Equity Commitments of $686.5 Million Record Q2 2024 Total Gross Fundings of $461.5 Million, an Increase of 28.7% Year-over-Year Record Q2 2024 Total Investment Income of $125.0 Million, an Increase of 7.5% Year-over-Year Q2 2024 Net Investment Income "NII" of $82.4 Million, or $0.51 per Share, an Increase of 8.8% Year-over-Year Q2 2024 NII Provides 128% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 93.3% and Net Regulatory Leverage of 83.9% Undistributed Earnings Spillover of $145.0 Million, or $0.89(1) per Ending Shares Outstanding Approximately $4.6 Billion of Assets Under Management, an In
Hercules Capital Announces Date for Release of Second Quarter 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its second quarter 2024 financial results conference call for Thursday, August 1, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access
Hercules Capital Announces Date of 2024 Annual Meeting of Stockholders
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), will conduct its 2024 Annual Meeting of Stockholders by virtual meeting on Thursday, June 20, 2024 at 9:00 a.m. (Pacific Time). The proxy statement for the meeting was filed on April 23, 2024 and mailed to stockholders of record as of April 19, 2024. 2024 Annual Meeting of Stockholders June 20, 2024 at 9:00 a.m. Pacific Time Virtual Meeting via Internet: www.virtualshareholdermeeting.com/HTGC2024 Matters to be voted on include: 1) election of three independent directors, 2) an advisory vote on the compensation of the Company's named executive officers, 3) authorization of the Company to sell or issue shares of its common
Hercules Capital Reports First Quarter 2024 Financial Results
Record Q1 2024 Total Gross Debt and Equity Commitments of $956.0 Million, an Increase of 81.7% Year-over-Year Record Q1 2024 Total Gross Fundings of $605.2 Million, an Increase of 27.1% Year-over-Year Q1 2024 Total Investment Income of $121.6 Million, an Increase of 15.7% Year-over-Year Q1 2024 Net Investment Income "NII" of $79.2 Million, or $0.50 per Share, an Increase of 20.9% Year-over-Year Q1 2024 NII Provides 125% Coverage of the Base Cash Distribution Conservative Balance Sheet Management with Net GAAP Leverage of 91.0% and Net Regulatory Leverage of 81.7% Undistributed Earnings Spillover of $142.7 Million, or $0.88(1) per Ending Shares Outstanding Approximately $4.5 Bi
Hercules Capital Celebrates 20th Anniversary with $20.0 Billion in Cumulative Originations
Two Decades of Fueling the Growth of the Innovation Economy Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), is celebrating its 20th year of originations activity by reaching the $20.0 billion milestone in total debt commitments. Founded in December 2003, and originating its first deal in 2004, the Company's mission was simple: Provide entrepreneurs with an alternative source of growth capital that complements a growth stage company's existing institutional financing. Today, Hercules Capital is the largest and leading specialty financing provider to innovative venture, growth and established stage companies, having partnered with over 650 technology and life sciences po
Hercules Capital Announces Date for Release of First Quarter 2024 Financial Results and Conference Call
Hercules Capital, Inc. (NYSE:HTGC) ("Hercules" or the "Company"), the largest and leading specialty financing provider to innovative venture, growth and established stage companies backed by some of the leading and top-tier venture capital and select private equity firms, today announced that it has scheduled its first quarter 2024 financial results conference call for Thursday, May 2, 2024, at 2:00 p.m. PT (5:00 p.m. ET). Hercules will release its financial results after market close that same day. To participate via telephone, please register here. Upon registration, all telephone participants will receive the dial-in number along with a unique PIN number that can be used to access the
Hercules Capital Inc. Large Ownership Changes
This live feed shows all institutional transactions in real time.
SEC Form SC 13G filed by Hercules Capital Inc.
SC 13G - Hercules Capital, Inc. (0001280784) (Subject)
SEC Form SC 13G/A filed by Hercules Capital Inc. (Amendment)
SC 13G/A - Hercules Capital, Inc. (0001280784) (Filed by)
SEC Form SC 13G filed by Hercules Capital Inc.
SC 13G - Hercules Capital, Inc. (0001280784) (Filed by)